1. Home
  2. BFS vs CBLL Comparison

BFS vs CBLL Comparison

Compare BFS & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BFS

Saul Centers Inc.

HOLD

Current Price

$33.54

Market Cap

770.9M

Sector

Real Estate

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$19.05

Market Cap

750.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFS
CBLL
Founded
1993
2014
Country
United States
United States
Employees
N/A
280
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
770.9M
750.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BFS
CBLL
Price
$33.54
$19.05
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$24.67
AVG Volume (30 Days)
54.7K
307.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
7.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.07
$29.57
Revenue Next Year
$7.05
$28.44
P/E Ratio
$30.48
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.16
$10.01
52 Week High
$36.51
$24.33

Technical Indicators

Market Signals
Indicator
BFS
CBLL
Relative Strength Index (RSI) 43.60 49.14
Support Level $32.53 $18.78
Resistance Level $35.18 $20.09
Average True Range (ATR) 0.88 0.72
MACD -0.19 0.18
Stochastic Oscillator 32.43 78.72

Price Performance

Historical Comparison
BFS
CBLL

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

About CBLL CeriBell Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: